Buy messages indicate funds looking to buy JNJ now. (They see higher prices next year, not nexr month.)I think they are taking profits on amgn and putting the money to work in JNJ6 months ago amgn and JNJ were both about the same price. Now Amgn is 15 points higher.
There are no problems with the stents.
Buy on weakness....this company is as solid as it comes.....
Why are the funds selling AMGN, and not BSX?AMGN may be doing well in making major inroads against PROCRIT and EPREX anemia drugs.Is BSX considered a shoo-in in as a soon to be competitor in the DE stent market?
Have any of you posters , JNJ , owners looked into a company call MIVT-English Company, I think, in regards to stents? JNJ should look at it !